Biosergen AB (OSTO:BIOSGN) Days Payable : 0.00 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Days Payable?

Biosergen AB's average Accounts Payable for the three months ended in Mar. 2024 was kr1.70 Mil. Biosergen AB's Cost of Goods Sold for the three months ended in Mar. 2024 was kr0.00 Mil.

The historical rank and industry rank for Biosergen AB's Days Payable or its related term are showing as below:

OSTO:BIOSGN' s Days Payable Range Over the Past 10 Years
Min: 3405.47 Med: 8837.56 Max: 12165.98
Current: 6580.05

During the past 4 years, Biosergen AB's highest Days Payable was 12165.98. The lowest was 3405.47. And the median was 8837.56.

OSTO:BIOSGN's Days Payable is ranked better than
94.04% of 721 companies
in the Biotechnology industry
Industry Median: 148.78 vs OSTO:BIOSGN: 6580.05

Biosergen AB's Days Payable declined from Mar. 2023 (2,825.02) to Mar. 2024 (0.00). It may suggest that Biosergen AB accelerated paying its suppliers.

Biosergen AB Days Payable Historical Data

The historical data trend for Biosergen AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosergen AB Days Payable Chart

Biosergen AB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Days Payable

12,165.98

8,837.56

3,405.47

Biosergen AB Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial									2,825.02	-	-	691.71	-

Competitive Comparison of Biosergen AB's Days Payable

For the Biotechnology subindustry, Biosergen AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosergen AB's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosergen AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Biosergen AB's Days Payable falls into.

Biosergen AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Biosergen AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (6.811	+	1.698)	/	2 )	/	0.456	*	365
=	4.2545					/	0.456	*	365
=	3,405.47

Biosergen AB's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (1.698	+	0)	/	1 )	/	0	*	365 / 4
=	1.698					/	0	*	365 / 4
=	N/A

Biosergen AB Days Payable Related Terms

Thank you for viewing the detailed overview of Biosergen AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosergen AB (OSTO:BIOSGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fogdevreten 2, Solna, SWE, 17165

Website

https://www.biosergen.net

Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway, and several other places worldwide. The company is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.

Biosergen AB (OSTO:BIOSGN) Headlines

No Headlines